A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients With Hepatitis C

Phoenix

San Diego

San Mateo

Lakewood

Bradenton

Gainesville

Atlanta

Chicago

Laurel

Worcester

Detroit

Kansas City

Albuquerque

New York

Cincinnati

Philadelphia

Germantown

San Antonio

Tacoma